Disclosures for "Acute and Subacute Neurovascular Impact of Cryptogenic Air Emboli")
-
Dr. Gummerson has nothing to disclose.
-
Dr. Parasram has nothing to disclose.
-
Dr. Peng has nothing to disclose.
-
Dr. Picard has nothing to disclose.
-
Dr. Kahn has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Kahn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Chronius. Dr. Kahn has stock in Coaptech. Dr. Kahn has stock in Quantum Labs. Dr. Kahn has stock in FVC Health. Dr. Kahn has stock in TEO Science . Dr. Kahn has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Angelus has nothing to disclose.
-
Dr. Bhatt has nothing to disclose.
-
Dr. De Havenon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Integra. Dr. De Havenon has stock in Certus. The institution of Dr. De Havenon has received research support from NIH/NINDS. The institution of Dr. De Havenon has received research support from Regeneron Pharmaceuticals. The institution of Dr. De Havenon has received research support from AMAG Pharmaceuticals. The institution of Dr. De Havenon has received research support from AMGEN. Dr. De Havenon has received publishing royalties from a publication relating to health care.
-
Dr. Jasne has nothing to disclose.
-
Dr. Magid-Bernstein has nothing to disclose.